Navigation Links
Sanovas Awarded Patent for Abrading Balloon Catheter for Extravasated Drug Delivery
Date:12/3/2013

SAUSALITO, Calif., Dec. 3, 2013 /PRNewswire/ -- Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,597,239 for the company's Abrading Balloon Catheter for Extravasated Drug Delivery.

The Abrading Balloon Catheter for Extravasated Drug Delivery is a multi-lumen balloon catheter that features abrasive outer surfaces upon the substrate of the balloons that are intended to abrade tissue and stimulate cellular function to optimize the osmotic uptake of therapeutic agents into target tissues. The device temporarily occludes a specific region to create a localized treatment chamber for the focal and/or circumferential delivery of various types of therapeutic agents to treat a variety of disease states via the company's patented methods of extravasated drug delivery.

"We believe clinicians will appreciate the broad utility of this asset," related Sanovas CEO, Larry Gerrans. "This will be an intelligent and effective device intended to significantly improve localized, precision therapies. It is analogous to the Swiss Army Knife of Drug Delivery Catheters."

The technology measures and modulates the volumetric pressure gradients of therapeutic agent(s) within the treatment chamber(s) to perfuse the agent(s) across the tissue membrane enabling controlled delivery of the agents directly to target tissues. The system affords clinicians substantial procedural control, including the ability to select the therapeutic agent(s) of their choice and to continuously circulate, irrigate, abrade, extravasate and evacuate the treatment site while mitigating the systemic release of the agent.

"This patent is a significant cornerstone to the company's NanoVas™ portfolio of Interventional Drug Delivery Solutions," said Gerrans. "These tools are vital to the continued growth and promise of Personalized Medicine."  

Sanovas expects to commercialize the technology in coordination with its various partners to meet unmet clinical needs in Pulmonology, Cardiology, Neurology and Uro-Gynecology.

About Sanovas

Sanovas' micro-surgical technology platform is designed to give surgeons the ability to access and visualize previously inaccessible areas of the body; enabling them to diagnose, treat and deliver drug and immune therapies to small diameter anatomy in entirely new ways.

Contact for Sanovas:

Steve Goldsmith
Vice President Marketing
sgoldsmith@sanovas.com
(415) 729- 9391 ext. 1023


'/>"/>
SOURCE Sanovas, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sanovas Launches Next Generation Surgical Imaging Technology
2. Sanovas Fills Corporate Bench with Industry Veterans In Clinical, Regulatory and Finance
3. Sanovas Forms Scientific Advisory Board to Support Development of Lung Cancer Technology
4. WPPS GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline
5. T1D Exchange Awarded $2.8M Grant by JDRF to Study Metformin and Type 1 Diabetes
6. NanoBio Awarded Up To $10 Million In NIH Funding To Develop A Pandemic Influenza Vaccine
7. Pfenex Inc. awarded a subcontract by Leidos to develop a scalable cGMP production process for a second key malaria antigen
8. AMRI Awarded Development and Manufacture Contract from the UK Government
9. Numotion Awarded Best Complex Rehab Provider
10. Isis Pharmaceuticals Stanley Crooke Awarded Corporate Forums Director of the Year
11. Access Pharmaceuticals Awarded Second European Patent for MuGard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... N.C. , Feb. 24, 2017 ... exploring ways to increase their self-service capabilities to ... Care Providers (HCPs). New research from ... pharma organizations have developed self-service website portals where ... This is just one of many findings to ...
(Date:2/24/2017)... 24 février 2017 ITL Limited, ( ASX : ITD ), ... ravie d,annoncer les excellents résultats semestriels clos le 31 ... Une présentation complète « Résultats et mise à jour sur ... . Faits marquants ... 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... Medivir AB (Nasdaq Stockholm: MVIR) ... Board of Directors that will be submitted to the ... representatives of the company,s three largest shareholders at the ... accepted a seat on the Nomination Committee, and the ... Nomination Committee was as follows:  ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 2017 , ... Houston dentist , Dr. Behzad Nazari, ... Center. Currently, patients can get single dental implants for $3,599 and All On ... more about these offers by contacting Antoine Dental Center. Both of these options ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. ... has officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio ...
(Date:2/24/2017)... ... ... Healthcare Associates of McKinney announced today that they have moved one ... 121, Suite 210, McKinney, Texas 75070. It is in the heart of the ... has grown, the need for more space has been paramount. This beautiful new ...
(Date:2/24/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has published a ... an astounding statement when he says that the entire Bible was written for the ... times so plainly that anyone should be able to see the time period. He ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... specializes in thought leadership , media relations, social media, content marketing and ... will be powered through Act-On, an intuitive marketing automation platform. , Rosica will ...
Breaking Medicine News(10 mins):